Eurovestech PLC
2 April 2001
For Immediate Release
2nd April, 2001
EUROVESTECH PLC
('Eurovestech' or 'the Company')
In accordance with the Company's stated intention to issue new ordinary shares
in order to make charitable donations, as set out in its Prospectus dated 6th
March, 2000, the Company announces that it has issued 600,000 new ordinary
shares, divided equally between six charitable organisations, pursuant to the
authority granted by a resolution dated 21st February, 2000.
Richard Bernstein, Chief Executive of the Company has paid the £6,000 nominal
value of the new ordinary shares to facilitate their issues.
In addition, Richard Bernstein has gifted 600,000 existing ordinary shares
from his personal shareholding divided equally between the same charities. He
is now interested in 59,400,000 ordinary shares representing 26.9 per cent of
the issued share capital of the Company.
As a result of the above transactions each of the following charities will
receive 200,000 Ordinary Shares;
* Leukaemia Research Fund
* Leuka 2000
* Listening Ear Merseyside
* International Paralympic Equestrian Committee
* Merlin Emergency Relief International
* Nordoff - Robbins Music Therapy
It is expected that dealings in the 600,000 new ordinary shares of the Company
will commence on 10th April, 2001.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.